11 nominees · 4 ballot items.
Election of directors; Ratification of Deloitte & Touche LLP as independent auditor; Advisory (non-binding) approval of named executive officer compensation (Say-on-Pay); Shareholder proposal to permit shareholder written consent (proponent: John Chevedden).
Election of eleven director nominees to serve until the next annual meeting.
Ratify Deloitte & Touche LLP as independent registered public accounting firm for fiscal year ending December 31, 2026.
Non-binding, advisory vote to approve the compensation of named executive officers as disclosed in the proxy statement.
The advisory Say-on-Pay proposal asks shareholders to approve, on a non-binding basis, the Company’s executive compensation policies and the compensation paid to named executive officers as disclosed in the proxy. Management supports this vote to confirm alignment of compensation design with the Company’s strategy and long-term shareholder value creation. The Company’s compensation program emphasizes variable pay (annual and long-term incentives), links pay to performance via Compensation Core Earnings, Compensation Core ROE and TSR metrics, and includes governance safeguards such as independent compensation consultant oversight, clawback policy, and double-trigger change-of-control vesting. The Compensation Committee concluded that 2025 outcomes (AIP funded at 176% of target, strong three-year performance share payout at 176% of target) reflect robust financial and strategic execution and thus recommends shareholders vote for the advisory approval. Shareholders’ prior strong support (approximately 92% in 2025) informs continued use of these practices and the Board will consider the vote’s outcome in future compensation decisions.
Shareholder proposal requesting the Board take steps to permit shareholders to act by written consent upon the minimum number of votes necessary to approve an action at a meeting where all shareholders are present and voting; proponent: John Chevedden.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | VANGUARD CAPITAL MANAGEMENT LLC | 6.57% | 17,997,591 | $2.4B |
| 2 | STATE STREET CORP | 5.86% | 16,058,482 | $2.2B |
| 3 | VANGUARD PORTFOLIO MANAGEMENT LLC | 5.81% | 15,919,750 | $2.2B |
| 4 | BlackRock, Inc. | 5.22% | 14,305,494 | $1.9B |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 2.67% | 7,308,928 | $990M |
| 6 | FMR LLC | 2.55% | 7,003,439 | $947M |
| 7 | BlackRock, Inc. | 2.16% | 5,919,649 | $801M |
| 8 | DIMENSIONAL FUND ADVISORS LP | 1.39% | 3,820,419 | $517M |
| 9 | FIRST TRUST ADVISORS LP | 1.26% | 3,455,229 | $467M |
| 10 | BlackRock, Inc. | 1.19% | 3,264,549 | $441M |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.